1. Home
  2. AZTA vs EVO Comparison

AZTA vs EVO Comparison

Compare AZTA & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZTA
  • EVO
  • Stock Information
  • Founded
  • AZTA 1978
  • EVO 1993
  • Country
  • AZTA United States
  • EVO Germany
  • Employees
  • AZTA N/A
  • EVO N/A
  • Industry
  • AZTA Industrial Machinery/Components
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • AZTA Technology
  • EVO Health Care
  • Exchange
  • AZTA Nasdaq
  • EVO Nasdaq
  • Market Cap
  • AZTA 1.8B
  • EVO 1.4B
  • IPO Year
  • AZTA 1995
  • EVO 2021
  • Fundamental
  • Price
  • AZTA $26.72
  • EVO $3.97
  • Analyst Decision
  • AZTA Buy
  • EVO Buy
  • Analyst Count
  • AZTA 3
  • EVO 2
  • Target Price
  • AZTA $50.67
  • EVO $5.90
  • AVG Volume (30 Days)
  • AZTA 1.1M
  • EVO 201.5K
  • Earning Date
  • AZTA 05-07-2025
  • EVO 05-06-2025
  • Dividend Yield
  • AZTA N/A
  • EVO N/A
  • EPS Growth
  • AZTA N/A
  • EVO N/A
  • EPS
  • AZTA N/A
  • EVO N/A
  • Revenue
  • AZTA $669,171,000.00
  • EVO $851,944,444.00
  • Revenue This Year
  • AZTA N/A
  • EVO $10.08
  • Revenue Next Year
  • AZTA $4.89
  • EVO $10.99
  • P/E Ratio
  • AZTA N/A
  • EVO N/A
  • Revenue Growth
  • AZTA 8.56
  • EVO 1.50
  • 52 Week Low
  • AZTA $23.91
  • EVO $2.84
  • 52 Week High
  • AZTA $63.58
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • AZTA 44.87
  • EVO 48.96
  • Support Level
  • AZTA $26.96
  • EVO $3.78
  • Resistance Level
  • AZTA $28.32
  • EVO $4.80
  • Average True Range (ATR)
  • AZTA 1.10
  • EVO 0.14
  • MACD
  • AZTA 0.19
  • EVO -0.04
  • Stochastic Oscillator
  • AZTA 15.71
  • EVO 18.63

About AZTA Azenta Inc.

Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has two reportable segments that are Life Sciences Products and Life Sciences Services. It generates a substantial part of its revenue from its Life Sciences Services segment.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: